|
in vitro fertilization |
23 |
|
pregnancy |
14 |
|
vitamin d |
13 |
|
antral follicle count |
11 |
|
frozen embryo transfer |
10 |
|
cumulative live birth rate |
8 |
|
live birth rate |
8 |
|
miscarriage |
8 |
|
anti-mullerian hormone |
7 |
|
ectopic pregnancy |
7 |
|
human spermatozoa |
7 |
|
ovarian response |
7 |
|
oviductal epithelial cell |
7 |
|
oxidative stress |
7 |
|
advanced glycation end-products |
6 |
|
dysglycaemia |
6 |
|
glutathione peroxidase |
6 |
|
ivf |
6 |
|
metabolic syndrome |
6 |
|
polycystic ovary syndrome |
6 |
|
reproductive medicine |
6 |
|
screening |
6 |
|
soluble receptor of advanced glycation end-products |
6 |
|
sperm fucosyltransferase-5 |
6 |
|
superoxide dismutase |
6 |
|
age |
5 |
|
anti-müllerian hormone |
5 |
|
box trainer |
5 |
|
fertilization |
5 |
|
first trimester |
5 |
|
hyaluronic acid |
5 |
|
infertility |
5 |
|
laparoscopy |
5 |
|
mifepristone |
5 |
|
oral progestogen |
5 |
|
ovarian response prediction index |
5 |
|
progesterone |
5 |
|
spermatozoa |
5 |
|
threatened miscarriage |
5 |
|
transfer medium |
5 |
|
ulipristal acetate |
5 |
|
vaginal bleeding |
5 |
|
alkaline phosphatase |
4 |
|
assisted reproductive technologies |
4 |
|
bologna criteria |
4 |
|
caffeine consumption |
4 |
|
cesarean section - adverse effects |
4 |
|
cicatrix - complications - pathology |
4 |
|
conscious sedation |
4 |
|
dehydroepiandrosterone |
4 |
|
endometrial polyp |
4 |
|
female |
4 |
|
follicle stimulating hor mone/administration & dosage |
4 |
|
follicle stimulating hormone/therapeutic use |
4 |
|
follicle-stimulating hormone |
4 |
|
food frequency questionnaire |
4 |
|
gonadotropins/administration & dosage |
4 |
|
gonadotropins/therapeutic use |
4 |
|
humans |
4 |
|
hydatidiform mole - diagnosis - etiology - therapy |
4 |
|
hysteroscopy |
4 |
|
infection |
4 |
|
oocyte retrieval |
4 |
|
ovarian sensitivity index |
4 |
|
ovary/drug effects |
4 |
|
ovulation induction |
4 |
|
pain relief |
4 |
|
poor ovarian response |
4 |
|
pregnancy outcome |
4 |
|
pregnant women |
4 |
|
premature ovarian insufficiency |
4 |
|
prenatal care |
4 |
|
testosterone |
4 |
|
transcutaneous electrical nerve stimulation |
4 |
|
transvaginal oocyte retrieval |
4 |
|
uterine neoplasms - diagnosis - etiology - therapy |
4 |
|
3-dimensional |
3 |
|
adverse pregnancy outcomes |
3 |
|
caesarean scar |
3 |
|
complications |
3 |
|
corifollitropin alfa |
3 |
|
early pregnancy assessment clinic |
3 |
|
ethnicity |
3 |
|
fet cycles |
3 |
|
group b streptococcus |
3 |
|
husband involvement in antenatal care |
3 |
|
infertility in-vitro fertilization |
3 |
|
intercycle variation |
3 |
|
nausea and vomiting in pregnancy |
3 |
|
patient preference |
3 |
|
preconception |
3 |
|
pregnancy rate |
3 |
|
retrospective cohort |
3 |
|
serum 25(oh)d concentration |
3 |
|
social support |
3 |
|
stimulated cycles |
3 |
|
vitamin d status |
3 |
|
assisted reproductive technology |
2 |
|
clinical pregnancy |
2 |
|
discriminatory level |
2 |
|
education |
2 |
|
endometrial biopsy |
2 |
|
gynaecology and fertility |
2 |
|
gynecologic ultrasound |
2 |
|
heterotopic pregnancy |
2 |
|
human chorionic gonadotropin level |
2 |
|
implantation failure |
2 |
|
in-vitro fertilization |
2 |
|
management |
2 |
|
obstetrics |
2 |
|
pregnancy of unknown location |
2 |
|
simulator training |
2 |
|
suturing |
2 |
|
elderly |
1 |
|
hong kong |
1 |
|
human chorionic gonadotrophin |
1 |
|
knowledge and practice |
1 |
|
methotrexate |
1 |
|
old-age homes |
1 |
|
severe acute respiratory syndrome (sars) |
1 |
